Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Fulcrum Therapeutics (FULC) Return on Assets (2020 - 2025)

Historic Return on Assets for Fulcrum Therapeutics (FULC) over the last 6 years, with Q3 2025 value amounting to 0.24%.

  • Fulcrum Therapeutics' Return on Assets fell 1800.0% to 0.24% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.24%, marking a year-over-year decrease of 1800.0%. This contributed to the annual value of 0.04% for FY2024, which is 3600.0% up from last year.
  • Latest data reveals that Fulcrum Therapeutics reported Return on Assets of 0.24% as of Q3 2025, which was down 1800.0% from 0.24% recorded in Q2 2025.
  • In the past 5 years, Fulcrum Therapeutics' Return on Assets ranged from a high of 0.07% in Q1 2025 and a low of 0.5% during Q2 2022
  • For the 5-year period, Fulcrum Therapeutics' Return on Assets averaged around 0.31%, with its median value being 0.36% (2023).
  • As far as peak fluctuations go, Fulcrum Therapeutics' Return on Assets plummeted by -3100bps in 2021, and later skyrocketed by 4700bps in 2025.
  • Quarter analysis of 5 years shows Fulcrum Therapeutics' Return on Assets stood at 0.33% in 2021, then crashed by -40bps to 0.46% in 2022, then rose by 22bps to 0.36% in 2023, then surged by 90bps to 0.04% in 2024, then plummeted by -569bps to 0.24% in 2025.
  • Its Return on Assets was 0.24% in Q3 2025, compared to 0.24% in Q2 2025 and 0.07% in Q1 2025.